Summary
MEDI3S is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €89,650 and a net result of €41,377. Equity is growing by about 82% per year across the filed financial years. Its solvency ranks better than 81% of 9,732 sector peers (NACE 64, financial year 2025). The company has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals.
Articles of association
What the company does
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- MEDI3S
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Vlaams Gewest, geen wijziging inzake het op de vennootschap toepasselijke taalregime” (deed in Dutch)
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- Each director alone
- Board ruleHow the board is made up, meets and takes decisions.
- “Natuurlijke personen of rechtspersonen, al dan niet aandeelhouder, 1” (deed in Dutch)“Intern bestuur, handelingen die wet of statuten aan algemene vergadering voorbehouden” (deed in Dutch)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Second Tuesday of June at 19:00
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Vormen vereist voor statutenwijziging, op elk moment door beslissing algemene vergadering” (deed in Dutch)
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Nog in natura voorhanden goederen op zelfde wijze verdeeld, netto actief onder alle aandeelhouders naar verhouding aantal aandelen” (deed in Dutch)